Access + Impact: Insights on Patient Services & Market Access
At eMAX Health, we believe better outcomes begin with smarter infrastructure. Access + Impact is where we share perspectives from across our enterprise and cover everything from scalable patient support programs to commercialization strategy and market access innovation.
Explore thought leadership, technology updates, and real-world best practices that help manufacturers deliver access, affordability, and adherence at every stage of the brand lifecycle.
Field Reimbursement Dashboards That Drive Real Results
Discover how HealthPACER® FRM dashboards give field teams real-time visibility into cases, improve provider experience, and accelerate patient access.
Inside the Decision Room: How to Pressure-Test Your Value Story for Formulary Success
Coverage isn’t only about rebates. P&T committees weigh evidence relevance, comparator choice, contracting tactics, and the strength of your value story. Learn how leading teams are using payer panels to pressure-test strategy before formulary placement decisions.
How Payers Are Scrutinizing Endpoints and What Evidence Resonates Most in 2025
Payers aren’t asking for more data—they’re demanding the right data. In 2025, endpoints that once secured access may no longer resonate. Manufacturers must validate their value story against evolving payer expectations or risk raising red flags that derail coverage and contracting decisions.
World Patient Safety Day: Building Safer Patient Access
On World Patient Safety Day, see how eMAX Health Patient Services embeds safety into access workflows for newborns, children, and their families.
Reducing Time-to-Therapy with HealthPACER® Workflows
See how HealthPACER® accelerates benefit verification, ePA, and appeals to cut delays, ease provider burden, and get patients on therapy faster.
The New Normal of Iterative Market Access: Why Static Annual Research is Dead
Static annual market access research can’t keep pace with today’s rapid policy, pricing, and payer shifts. Learn why high-performing pharmaceutical teams are adopting iterative, agile insight loops, and how this new model is transforming launch and portfolio strategy.
A New Federal Committee on Care Financing: What It Means for Patient Services
CMS’s new Healthcare Advisory Committee targets efficiency and outcomes. Here’s how patient services can adapt now to reduce burden and speed access.
A New Federal Healthcare Advisory Committee: Implications for Pharma Market Access
HHS and CMS have formed a new Healthcare Advisory Committee to reshape how federal payers finance and deliver care. Learn how this could impact pharma market access—and why agile insight platforms like MAVA™ are essential to adapt.
Hybrid Patient Support Models That Put You in Control
Hybrid and insourced patient support models give pharmaceutical manufacturers the flexibility and control missing in fully outsourced hubs. With HealthPACER® and expert operational support, eMAX Health Patient Services helps brands streamline access, strengthen compliance, and design scalable patient services that adapt to market demands.
Why Flexibility Matters in Pharma Support Programs
Many pharma manufacturers are stuck between outdated patient support models and rising access challenges. In this post, eMAX Health Patient Services explores how flexible strategies like hybrid support models, scalable tech platforms, and alternative funding solutions, can help manufacturers modernize their Patient Assistance Programs and improve outcomes across the product lifecycle.